Power2Drive Europe: Contributing to the Energy Transition With Bidirectional Charging
E-mobility is about much more than driving on climate-neutral electricity from renewable sources. The batteries of electric vehicles can be used as temporary storage. And it’s not just vehicle owners who benefit from this: In the medium-term, bidirectional charging can take the burden off distribution grids while making them more flexible. Power2Drive Europe, the international exhibition for charging infrastructure and e-mobility, showcases the latest state of the art. As part of The smarter E Europe, the continent’s largest alliance of exhibitions for the energy industry, it will take place from June 19–21, 2024, at Messe München. The Power2Drive Europe Conference, the industry's meeting point and forum for exchange and discourse among experts, stakeholders, and thought leaders in the new mobility sector, kicks off one day earlier.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240502196803/en/
Power2Drive Europe 2024 highlights cutting-edge trends and technologies in bidirectional charging. Credit: Solar Promotion GmbH
There are three types of applications that bidirectional charging of EV traction batteries can be used for: In vehicle-to-home (V2H) and vehicle-to-building (V2B) solutions, the storage and consumption of the electricity takes place entirely in the user’s system, meaning in a private household or a company, behind the meter. In vehicle-to-grid (V2G) solutions, the e-car is part of the power system and can provide flexibility services to the distribution grid by storing electricity and feeding it back into the grid.
Potentials of bidirectional charging
A study conducted by NRW.Energy4Climate and e-mobil BW forecasts that by 2035, approximately 33 million battery electric vehicles could be on the roads in Germany. Of these vehicles, about 65 percent are projected to support bidirectional charging. This translates to a potential of around 7.6 million vehicles serving as mobile energy storage units. Remarkably, this capacity, reaching up to 380 gigawatt-hours, surpasses the demand for stationary battery storage by threefold. These findings underscore the significant potential of electromobility in facilitating the integration of renewable energies.
V2G and regulatory requirements
The basic regulatory legal framework is still missing for the V2G solutions that are immediately useful for the grid to work. Markus Elsässer explains that “Bidirectional charging will be a decisive element of the energy transition. The technology has the potential of effectively taking the burden off distribution grids and making the more flexible.”
Markus Fendt, Managing Director of The Mobility House, emphasizes the societal and economic importance of this application: “V2G bidirectional charging dramatically reduces redispatch. Based on the price of electricity alone, every electric car could have been driven 40,000 kilometers at no extra cost in 2022. It also reduces the need for grid expansion. And last but not least, we would realize innovation in our leading industry, the automotive industry, in Germany.
Power2Drive Europe sees massive growth
Within the range of topics at The smarter E Europe, e-mobility is becoming more important and recognized: In a survey, a third of the trade visitors of all exhibitions of The smarter E Europe expressed an interest in the topic e-mobility. Consequently, the exhibition space of Power2Drive Europe has been expanded by 80 percent compared to the previous year.
Power2Drive Europe
Power2Drive Europe is the international exhibition for charging infrastructure and e-mobility. Under the motto “Charging the Future of Mobility”, it is the ideal industry meeting point for players from the world of sustainable mobility. The focus is on charging infrastructure, electromobility, mobility services and sector coupling. Power2Drive Europe will take place from June 19–21, 2024 as part of The smarter E Europe at Messe München.
More information: www.powertodrive.de
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240502196803/en/
Contact information
Roberto Freiberger
ressourcenmangel an der Panke GmbH
+491638430943
press@thesmarter.de
Peggy Zilay
Solar Promotion GmbH
Postfach 100 170
75101 Pforzheim
zilay@solarpromotion.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval of ALYFTREK ™ , a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 21:46:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and to improve the lives of people living with cystic fibrosis,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal le
Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non- F508del TRIKAFTA-Responsive Variants20.12.2024 21:35:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their disease for the first time. “Since its first approval in 2019, TRIKAFTA has had a transformative impact on tens of thousands of people living with cystic fibrosis,” sai
HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 20:32:00 CET | Press Release
Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa
SBC Medical Group Co., Ltd. Sells Two Subsidiaries20.12.2024 13:00:00 CET | Press Release
On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas. The subsidiaries being sold operate in the following industries: Kijimadaira: Ski resort operations SNA: Flight training operations The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To e
Aarhus University: New Global Study Sheds Light on the Learning Crisis: Three Years After COVID-1920.12.2024 13:00:00 CET | Press Release
TIMSS 2023 has revealed an alarming global learning crisis exacerbated by the COVID-19 pandemic. Compared to the long term trend in progress in mathematics and science achievement has not only stalled but reversed when taking school closures into account, with the most vulnerable students facing the steepest losses. Key Findings Global Achievement Decline: A 0.11 standard deviation drop in student performance reflects the pandemic's lasting impact. Disproportionate Impact: Low performers, girls, and language minorities faced losses up to twice the average (0.22 standard deviations), deepening existing inequities. Regional Variations: Countries with prolonged school closures and limited remote learning resources experienced the steepest declines. Why This Matters School closures disrupted the education of over one billion children worldwide, with disadvantaged students suffering the most. “The widening gender gap in STEM fields is particularly troubling,” said Christian Kjeldsen, incomi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom